UnknownNot Applicable

Vitrification of Oocytes Matured by CAPA-IVM

Peru20 participantsStarted 2023-12

Plain-language summary

It has been reported that the potential of In Vitro matured oocytes might be affected by the vitrification process. In fact, the freezing and thawing procedures routinely used in IVF laboratories, have not yet been adapted to oocytes coming from early antral follicles (normally used for In Vitro Maturation). This study aims to compare 2 existing protocols for the Vitrification of In Vitro matured oocytes.

Who can participate

Age range20 Years – 37 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Either * Patients with Polycystic ovary morphology: At least 25 follicles (2-9 mm) throughout the ovary and/or increased ovarian volume (\>10ml) (it is enough for 1 ovary to meet these criteria) * Patients with good ovarian reserve: High antral follicle count (AFC): ≥ 20 antral follicles in both ovaries or Anti-müllerian hormone (AMH) value ≥3.5 ng/ml In both cases, without significant uterine or ovarian anomalies Exclusion Criteria: * There are contraindications for the administration of gonadotropins, oral contraceptives and/or other drugs used in the framework of the present study. * Preimplantation Genetic Testing (PGT) Cycles * Oocyte donation cycles * Medical contraindication for pregnancy. * High grade endometriosis (\> grade 2) * Cases with extremely poor sperm

What they're measuring

Oocyte survival rate

Timeframe: 6 months

Trial details

NCT IDNCT06157619

SponsorCentro de Fertilidad y Reproducción Asistida, Peru

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-05

Contact for this trial

Sergio Romero, PhD

+51-1-2230363 sergioromero@cefra.com.pe

View on ClinicalTrials.gov More Fertility Preservation trials